Cargando…
Immunologically active parvovirus B19 peptide; comprises capsid protein VP1 or VP2 fragment; application to recombinant vaccine construction and disease diagnosis; protein sequence
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
1992
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131651/ http://dx.doi.org/10.1016/0264-410X(92)90031-E |
| _version_ | 1783517287037272064 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7131651 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 1992 |
| publisher | Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71316512020-04-08 Immunologically active parvovirus B19 peptide; comprises capsid protein VP1 or VP2 fragment; application to recombinant vaccine construction and disease diagnosis; protein sequence Vaccine Article Published by Elsevier Ltd. 1992 2002-11-13 /pmc/articles/PMC7131651/ http://dx.doi.org/10.1016/0264-410X(92)90031-E Text en © 1992 Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Immunologically active parvovirus B19 peptide; comprises capsid protein VP1 or VP2 fragment; application to recombinant vaccine construction and disease diagnosis; protein sequence |
| title | Immunologically active parvovirus B19 peptide; comprises capsid protein VP1 or VP2 fragment; application to recombinant vaccine construction and disease diagnosis; protein sequence |
| title_full | Immunologically active parvovirus B19 peptide; comprises capsid protein VP1 or VP2 fragment; application to recombinant vaccine construction and disease diagnosis; protein sequence |
| title_fullStr | Immunologically active parvovirus B19 peptide; comprises capsid protein VP1 or VP2 fragment; application to recombinant vaccine construction and disease diagnosis; protein sequence |
| title_full_unstemmed | Immunologically active parvovirus B19 peptide; comprises capsid protein VP1 or VP2 fragment; application to recombinant vaccine construction and disease diagnosis; protein sequence |
| title_short | Immunologically active parvovirus B19 peptide; comprises capsid protein VP1 or VP2 fragment; application to recombinant vaccine construction and disease diagnosis; protein sequence |
| title_sort | immunologically active parvovirus b19 peptide; comprises capsid protein vp1 or vp2 fragment; application to recombinant vaccine construction and disease diagnosis; protein sequence |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131651/ http://dx.doi.org/10.1016/0264-410X(92)90031-E |